Therapeutic Asset Ratings
603 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
mq719
Angiosarcoma
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
mq719
Basal Cell Carcinoma
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
mq719
Skin Basal Cell Carcinoma
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
mq719
Skin Neoplasm
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
mq719
Extramammary Paget Disease
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
mq719
Kaposi'S Sarcoma
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
mq719
Squamous Cell Carcinoma
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
mq719
Sebaceous Adenocarcinoma
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Msk-Tcr5
Unresectable Solid Tumor
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
PEGFILGRASTIM
Amyloidosis
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Pembrolizumab
Skin Appendage Carcinoma
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Pembrolizumab
Skin Basal Cell Carcinoma
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Pembrolizumab
Skin Neoplasm
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Pembrolizumab
Extramammary Paget Disease
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Pembrolizumab
Sebaceous Adenocarcinoma
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Rimiducid
Her2-Receptor Negative Breast Cancer
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Romosozumab
Osteoporosis
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Ruxolitinib
Neoplasm Of Mature T-Cells Or NK-Cells
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Ruxolitinib
T-Cell Large Granular Lymphocyte Leukemia
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Tisagenlecleucel
Transformed Follicular Lymphoma to Diffuse Large B Cell Lymphoma
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
VIPIVOTIDE TETRAXETAN
Diffuse Astrocytoma
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
VIPIVOTIDE TETRAXETAN
Diffuse Midline Glioma, H3 K27-Altered
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
VIPIVOTIDE TETRAXETAN
Diffuse Pediatric-Type High-Grade Glioma, H3-Wildtype And IDH-Wildtype
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
YSNVz
Acute Myeloid Leukemia
Memorial Sloan Kettering Cancer Center
P1
CC
(43)
Icasp9M28Z T Cell Infusions
Mesothelioma
Memorial Sloan Kettering Cancer Center
P1/2
CC
(43)
Showing 426 to 450 of 603 assets
Previous
Page 18 of 25
Next
